BEAT
HEALTHCAREHeartBeam Inc
$0.86+0.03 (+3.13%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BEAT Today?
No stock-specific AI insight has been generated for BEAT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.54$4.00
$0.86
Fundamentals
Market Cap$46M
P/E Ratio—
EPS$-0.62
Dividend Yield—
Dividend / Share—
ROE-9.9%
Profit Margin—
Debt / Equity—
Trading
Volume486K
Avg Volume (10D)—
Shares Outstanding53.6M
BEAT News
21 articles- HeartBeam (BEAT) Expands Concierge Cardiology Footprint With Atelier Health AgreementYahoo Finance·May 7, 2026
- HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge PracticeYahoo Finance·May 7, 2026
- HeartBeam (BEAT) Tackles Heart Disease With Next-Generation ECG SolutionsYahoo Finance·May 6, 2026
- HeartBeam (BEAT) to Host Q1 2026 Earnings Call and Provide Strategic UpdatesYahoo Finance·Apr 30, 2026
- HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern TimeYahoo Finance·Apr 30, 2026
- HeartBeam (BEAT): 10 Best NASDAQ Growth Stocks to Buy and Hold ForeverYahoo Finance·Apr 24, 2026
- HeartBeam (BEAT) Collaborates to Advance Next-Gen ECG SolutionsYahoo Finance·Apr 24, 2026
- HeartBeam (BEAT) Closes $10M Public Offering to Advance Cardiac Technology CommercializationYahoo Finance·Apr 17, 2026
- HeartBeam Announces Closing of $10 Million Public Offering of Common StockYahoo Finance·Apr 16, 2026
- HeartBeam (BEAT) Launches Proposed Public Offering to Support Commercialization and AI InitiativesYahoo Finance·Apr 15, 2026
- HeartBeam Announces Pricing of $10 Million Public Offering of Common StockYahoo Finance·Apr 15, 2026
- HeartBeam Announces Proposed Public Offering of Common StockYahoo Finance·Apr 14, 2026
- How Decentralized AI is Unlocking Value in Cardiac DiagnosticsBenzinga·Mar 27, 2026
- HeartBeam (BEAT) Partners With Mount Sinai to Accelerate AI-ECG Development and ValidationYahoo Finance·Mar 25, 2026
- HeartBeam (BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical DevelopmentYahoo Finance·Mar 13, 2026
- HeartBeam, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 13, 2026
- HeartBeam Inc (BEAT) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges with ...Yahoo Finance·Mar 13, 2026
- HeartBeam (BEAT) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 12, 2026
- HeartBeam Reports Fourth Quarter and Full Year 2025 ResultsYahoo Finance·Mar 12, 2026
- HeartBeam (BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm DevelopmentYahoo Finance·Mar 10, 2026
- HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the HomeYahoo Finance·Mar 10, 2026
All 21 articles loaded
Price Data
Open$0.83
Previous Close$0.83
Day High$0.87
Day Low$0.83
52 Week High$4.00
52 Week Low$0.54
52-Week Range
$0.54$4.00
$0.86
Fundamentals
Market Cap$46M
P/E Ratio—
EPS$-0.62
Dividend Yield—
Dividend / Share—
ROE-9.9%
Profit Margin—
Debt / Equity—
Trading
Volume486K
Avg Volume (10D)—
Shares Outstanding53.6M
About HeartBeam Inc
BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.
HEALTHCAREHEALTH INFORMATION SERVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICHEALTH INFORMATION SERVICES
CIK—
Composite FIGI—
Share Class FIGI—